Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

The sensor accurately measures thallium ions in solutions with high selectivity.

SQSTM1 gene issues may increase the risk of alopecia areata.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

MitoQ may help treat hair loss by boosting hair growth pathways.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.